Zacks: Brokerages Expect Beyondspring Inc (BYSI) to Announce -$0.76 Earnings Per Share

Equities analysts forecast that Beyondspring Inc (NASDAQ:BYSI) will post earnings per share of ($0.76) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Beyondspring’s earnings, with the highest EPS estimate coming in at ($0.73) and the lowest estimate coming in at ($0.79). The firm is scheduled to issue its next quarterly earnings results on Friday, April 27th.

According to Zacks, analysts expect that Beyondspring will report full-year earnings of ($4.41) per share for the current fiscal year. For the next year, analysts forecast that the business will report earnings of ($3.71) per share, with EPS estimates ranging from ($4.53) to ($2.89). Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for Beyondspring.

Beyondspring (NASDAQ:BYSI) last announced its quarterly earnings data on Thursday, November 9th. The company reported ($0.68) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.69) by $0.01.

A number of equities research analysts have recently weighed in on BYSI shares. Maxim Group set a $52.00 price objective on shares of Beyondspring and gave the company a “buy” rating in a report on Thursday, December 14th. HC Wainwright set a $60.00 price objective on shares of Beyondspring and gave the company a “buy” rating in a report on Friday, December 15th. Zacks Investment Research downgraded shares of Beyondspring from a “hold” rating to a “sell” rating in a research report on Monday, November 13th. Finally, Seaport Global Securities began coverage on shares of Beyondspring in a research report on Tuesday, December 5th. They issued a “buy” rating and a $56.00 target price on the stock. One analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $54.50.

Shares of Beyondspring (NASDAQ:BYSI) traded down $0.99 on Friday, hitting $25.74. 6,346 shares of the stock were exchanged, compared to its average volume of 2,575. Beyondspring has a fifty-two week low of $16.55 and a fifty-two week high of $48.49.

An institutional investor recently bought a new position in Beyondspring stock. Tanaka Capital Management Inc. bought a new stake in Beyondspring Inc (NASDAQ:BYSI) during the second quarter, according to its most recent disclosure with the SEC. The firm bought 21,322 shares of the company’s stock, valued at approximately $914,000. Beyondspring comprises about 2.1% of Tanaka Capital Management Inc.’s holdings, making the stock its 16th largest position. Tanaka Capital Management Inc. owned approximately 0.10% of Beyondspring at the end of the most recent quarter. Institutional investors own 1.22% of the company’s stock.

WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/01/13/zacks-brokerages-expect-beyondspring-inc-bysi-to-announce-0-76-earnings-per-share.html.

Beyondspring Company Profile

BeyondSpring Inc is a global clinical-stage biopharmaceutical company. The Company is focused on the development of cancer therapies. The Company is engaged in advancing its lead product, Plinabulin, into a Phase II/III clinical trial for the reduction of docetaxel chemotherapy-induced severe, grade 4 neutropenia; a Phase II/III clinical trial for the prevention of non-docetaxel chemotherapy-induced severe, grade 4 neutropenia, and a Phase III clinical trial as an anticancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC).

Get a free copy of the Zacks research report on Beyondspring (BYSI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Beyondspring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beyondspring and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply